158 related articles for article (PubMed ID: 7861225)
1. Paradoxical elevation of Ki-67 labeling with protein kinase inhibition in malignant gliomas.
Couldwell WT; Weiss MH; Law RE; Hinton DR
J Neurosurg; 1995 Mar; 82(3):461-8. PubMed ID: 7861225
[TBL] [Abstract][Full Text] [Related]
2. Protein kinase C inhibitors suppress cell growth in established and low-passage glioma cell lines. A comparison between staurosporine and tamoxifen.
Baltuch GH; Couldwell WT; Villemure JG; Yong VW
Neurosurgery; 1993 Sep; 33(3):495-501; discussion 501. PubMed ID: 8413883
[TBL] [Abstract][Full Text] [Related]
3. Combination therapy with irinotecan and protein kinase C inhibitors in malignant glioma.
Chen TC; Su S; Fry D; Liebes L
Cancer; 2003 May; 97(9 Suppl):2363-73. PubMed ID: 12712458
[TBL] [Abstract][Full Text] [Related]
4. Enhanced protein kinase C activity correlates with the growth rate of malignant gliomas in vitro.
Couldwell WT; Uhm JH; Antel JP; Yong VW
Neurosurgery; 1991 Dec; 29(6):880-6; discussion 886-7. PubMed ID: 1758601
[TBL] [Abstract][Full Text] [Related]
5. Disparity in expression of protein kinase C alpha in human glioma versus glioma-derived primary cell lines: therapeutic implications.
Zellner A; Fetell MR; Bruce JN; De Vivo DC; O'Driscoll KR
Clin Cancer Res; 1998 Jul; 4(7):1797-802. PubMed ID: 9676858
[TBL] [Abstract][Full Text] [Related]
6. Protein kinase C and growth regulation of pituitary adenomas.
Couldwell WT; Law RE; Hinton DR; Gopalakrishna R; Yong VW; Weiss MH
Acta Neurochir Suppl; 1996; 65():22-6. PubMed ID: 8738488
[TBL] [Abstract][Full Text] [Related]
7. Protein kinase C inhibitors induce apoptosis in human malignant glioma cell lines.
Couldwell WT; Hinton DR; He S; Chen TC; Sebat I; Weiss MH; Law RE
FEBS Lett; 1994 May; 345(1):43-6. PubMed ID: 8194597
[TBL] [Abstract][Full Text] [Related]
8. Relationship between Ki-67 labeling index and survival in high-grade glioma patients treated after surgery with tamoxifen.
Mastronardi L; Guiducci A; Puzzilli F; Ruggeri A
J Neurosurg Sci; 1999 Dec; 43(4):263-70. PubMed ID: 10864388
[TBL] [Abstract][Full Text] [Related]
9. Effect of tamoxifen on DNA synthesis and proliferation of human malignant glioma lines in vitro.
Pollack IF; Randall MS; Kristofik MP; Kelly RH; Selker RG; Vertosick FT
Cancer Res; 1990 Nov; 50(22):7134-8. PubMed ID: 2224848
[TBL] [Abstract][Full Text] [Related]
10. The efficacy of tamoxifen as an antiproliferative agent in vitro for benign and malignant pediatric glial tumors.
Pollack IF; Kawecki S
Pediatr Neurosurg; 1995; 22(6):281-8. PubMed ID: 7577661
[TBL] [Abstract][Full Text] [Related]
11. Effect of staurosporine on MOLT-4 cell progression through G2 and on cytokinesis.
Traganos F; Gong J; Ardelt B; Darzynkiewicz Z
J Cell Physiol; 1994 Mar; 158(3):535-44. PubMed ID: 8126077
[TBL] [Abstract][Full Text] [Related]
12. Response of malignant glioma cell lines to activation and inhibition of protein kinase C-mediated pathways.
Pollack IF; Randall MS; Kristofik MP; Kelly RH; Selker RG; Vertosick FT
J Neurosurg; 1990 Jul; 73(1):98-105. PubMed ID: 2161913
[TBL] [Abstract][Full Text] [Related]
13. Blocking of glioma proliferation in vitro and in vivo and potentiating the effects of BCNU and cisplatin: UCN-01, a selective protein kinase C inhibitor.
Pollack IF; Kawecki S; Lazo JS
J Neurosurg; 1996 Jun; 84(6):1024-32. PubMed ID: 8847567
[TBL] [Abstract][Full Text] [Related]
14. Staurosporine differentially inhibits glioma versus non-glioma cell lines.
Baltuch GH; Dooley NP; Couldwell WT; Yong VW
J Neurooncol; 1993 May; 16(2):141-7. PubMed ID: 8289091
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of the growth of glioblastomas by CGP 41251, an inhibitor of protein kinase C, and by a phorbol ester tumor promoter.
Begemann M; Kashimawo SA; Choi YA; Kim S; Christiansen KM; Duigou G; Mueller M; Schieren I; Ghosh S; Fabbro D; Lampen NM; Heitjan DF; Schiff PB; Bruce JN; Weinstein IB
Clin Cancer Res; 1996 Jun; 2(6):1017-30. PubMed ID: 9816263
[TBL] [Abstract][Full Text] [Related]
16. Application of flow cytometry for evaluating clinical prognosis and histopathological grade of human glioma.
Lin YW; Tai SH; Chang CC; Chao LC; Wen MJ; Huang YH; Hung HY; Lee EJ
Neurol Res; 2016 Jul; 38(7):625-33. PubMed ID: 27264544
[TBL] [Abstract][Full Text] [Related]
17. Cell cycle kinetic effects of tamoxifen on human breast cancer cells. Flow cytometric analyses of DNA content, BrdU labeling, Ki-67, PCNA, and statin expression.
Danova M; Pellicciari C; Zibera C; Mangiarotti R; Gibelli N; Giordano M; Wang E; Mazzini G; Riccardi A
Ann N Y Acad Sci; 1993 Nov; 698():174-81. PubMed ID: 7904138
[TBL] [Abstract][Full Text] [Related]
18. Growth inhibition induced by Ro 31-8220 and calphostin C in human glioblastoma cell lines is associated with apoptosis and inhibition of CDC2 kinase.
Begemann M; Kashimawo SA; Lunn RM; Delohery T; Choi YJ; Kim S; Heitjan DF; Santella RM; Schiff PB; Bruce JN; Weinstein IB
Anticancer Res; 1998; 18(5A):3139-52. PubMed ID: 9858877
[TBL] [Abstract][Full Text] [Related]
19. A comparison of the relative chemosensitivity of human gliomas to tamoxifen and n-desmethyltamoxifen in vitro.
Vertosick FT; Selker RG; Randall MS; Kristofik MP; Rehn T
J Neurooncol; 1994; 19(2):97-103. PubMed ID: 7964994
[TBL] [Abstract][Full Text] [Related]
20. Protein kinase C inhibition by UCN-01 induces apoptosis in human glioma cells in a time-dependent fashion.
Bredel M; Pollack IF; Freund JM; Rusnak J; Lazo JS
J Neurooncol; 1999 Jan; 41(1):9-20. PubMed ID: 10222418
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
